Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Lifestyle Medicine in Diabetes Care: The Lifedoc Health Model

R. Nieto-Martinez, C. Neira, D. de Oliveira, A. Velasquez-Rodriguez, A. Neira, P. Velasquez-Rodriguez, G. Garcia, JP. González-Rivas, JI. Mechanick, P. Velasquez-Mieyer

. 2023 ; 17 (3) : 336-354. [pub] 20220603

Status neindexováno Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc23009857

INTRODUCTION: The relevance of lifestyle medicine in diabetes treatment is now incorporated in clinical practice guidelines but finding an exemplar for the creation of a Lifestyle Medicine Program (LMP) is a difficult task. AIM: To use Lifedoc Health (LDH) as a LMP exemplar by describing their multidisciplinary team (MDT) approach to diabetes care along with tactics to address sustainability challenges. RESULTS: The LDH model facilitates early activation of patients with diabetes and other cardiometabolic risk factors, MDT approaches, and protocols/policies that are able to overcome barriers to equitable healthcare in the community. Specific programmatic targets are clinical outcomes, effective dissemination, economic viability, and sustainability. Infrastructure centers on patient-driven problem-based visits, shared medical appointments, telemedicine, and patient tracking. Further discussions on program conceptualization and operationalization are provided. CONCLUSION: Even though strategic plans for LMPs that specialize in diabetes care are well represented in the literature, implementation protocols, and performance metrics are lacking. The LDH experience provides a starting point for those healthcare professionals interested in translating ideas into action.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23009857
003      
CZ-PrNML
005      
20230721095432.0
007      
ta
008      
230707s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1177/15598276221103470 $2 doi
035    __
$a (PubMed)37304744
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Nieto-Martinez, Ramfis $u , Memphis, TN, USA (RN-M, CN, AN, PV-R, GG, PV-M); Departments of Global Health and Population and Epidemiology, Harvard TH Chan School of Public Health, LifeDoc Health, Boston, MA, USA (RN-M, JPG-R); Harvard University, Caracas, Venezuela (RN-M, DdO, JPG-R); Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Memphis, TN, USA (CN, AV-R, PV-M); International Clinical Research Centre (ICRC), LifeDoc Research, Czech Republic (JPG-R); and The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, and Division of Endocrinology, Diabetes and Bone Disease, St Anne's University Hospital Brno (FNUSA), New York, NY, USA (JIM)Icahn School of Medicine at Mount Sinai $1 https://orcid.org/0000000205757534
245    10
$a Lifestyle Medicine in Diabetes Care: The Lifedoc Health Model / $c R. Nieto-Martinez, C. Neira, D. de Oliveira, A. Velasquez-Rodriguez, A. Neira, P. Velasquez-Rodriguez, G. Garcia, JP. González-Rivas, JI. Mechanick, P. Velasquez-Mieyer
520    9_
$a INTRODUCTION: The relevance of lifestyle medicine in diabetes treatment is now incorporated in clinical practice guidelines but finding an exemplar for the creation of a Lifestyle Medicine Program (LMP) is a difficult task. AIM: To use Lifedoc Health (LDH) as a LMP exemplar by describing their multidisciplinary team (MDT) approach to diabetes care along with tactics to address sustainability challenges. RESULTS: The LDH model facilitates early activation of patients with diabetes and other cardiometabolic risk factors, MDT approaches, and protocols/policies that are able to overcome barriers to equitable healthcare in the community. Specific programmatic targets are clinical outcomes, effective dissemination, economic viability, and sustainability. Infrastructure centers on patient-driven problem-based visits, shared medical appointments, telemedicine, and patient tracking. Further discussions on program conceptualization and operationalization are provided. CONCLUSION: Even though strategic plans for LMPs that specialize in diabetes care are well represented in the literature, implementation protocols, and performance metrics are lacking. The LDH experience provides a starting point for those healthcare professionals interested in translating ideas into action.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Neira, Claudia $u , Memphis, TN, USA (RN-M, CN, AN, PV-R, GG, PV-M); Departments of Global Health and Population and Epidemiology, Harvard TH Chan School of Public Health, LifeDoc Health, Boston, MA, USA (RN-M, JPG-R); Harvard University, Caracas, Venezuela (RN-M, DdO, JPG-R); Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Memphis, TN, USA (CN, AV-R, PV-M); International Clinical Research Centre (ICRC), LifeDoc Research, Czech Republic (JPG-R); and The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, and Division of Endocrinology, Diabetes and Bone Disease, St Anne's University Hospital Brno (FNUSA), New York, NY, USA (JIM)Icahn School of Medicine at Mount Sinai
700    1_
$a de Oliveira, Diana $u , Memphis, TN, USA (RN-M, CN, AN, PV-R, GG, PV-M); Departments of Global Health and Population and Epidemiology, Harvard TH Chan School of Public Health, LifeDoc Health, Boston, MA, USA (RN-M, JPG-R); Harvard University, Caracas, Venezuela (RN-M, DdO, JPG-R); Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Memphis, TN, USA (CN, AV-R, PV-M); International Clinical Research Centre (ICRC), LifeDoc Research, Czech Republic (JPG-R); and The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, and Division of Endocrinology, Diabetes and Bone Disease, St Anne's University Hospital Brno (FNUSA), New York, NY, USA (JIM)Icahn School of Medicine at Mount Sinai
700    1_
$a Velasquez-Rodriguez, Andrés $u , Memphis, TN, USA (RN-M, CN, AN, PV-R, GG, PV-M); Departments of Global Health and Population and Epidemiology, Harvard TH Chan School of Public Health, LifeDoc Health, Boston, MA, USA (RN-M, JPG-R); Harvard University, Caracas, Venezuela (RN-M, DdO, JPG-R); Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Memphis, TN, USA (CN, AV-R, PV-M); International Clinical Research Centre (ICRC), LifeDoc Research, Czech Republic (JPG-R); and The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, and Division of Endocrinology, Diabetes and Bone Disease, St Anne's University Hospital Brno (FNUSA), New York, NY, USA (JIM)Icahn School of Medicine at Mount Sinai
700    1_
$a Neira, Andres $u , Memphis, TN, USA (RN-M, CN, AN, PV-R, GG, PV-M); Departments of Global Health and Population and Epidemiology, Harvard TH Chan School of Public Health, LifeDoc Health, Boston, MA, USA (RN-M, JPG-R); Harvard University, Caracas, Venezuela (RN-M, DdO, JPG-R); Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Memphis, TN, USA (CN, AV-R, PV-M); International Clinical Research Centre (ICRC), LifeDoc Research, Czech Republic (JPG-R); and The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, and Division of Endocrinology, Diabetes and Bone Disease, St Anne's University Hospital Brno (FNUSA), New York, NY, USA (JIM)Icahn School of Medicine at Mount Sinai
700    1_
$a Velasquez-Rodriguez, Pedro $u , Memphis, TN, USA (RN-M, CN, AN, PV-R, GG, PV-M); Departments of Global Health and Population and Epidemiology, Harvard TH Chan School of Public Health, LifeDoc Health, Boston, MA, USA (RN-M, JPG-R); Harvard University, Caracas, Venezuela (RN-M, DdO, JPG-R); Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Memphis, TN, USA (CN, AV-R, PV-M); International Clinical Research Centre (ICRC), LifeDoc Research, Czech Republic (JPG-R); and The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, and Division of Endocrinology, Diabetes and Bone Disease, St Anne's University Hospital Brno (FNUSA), New York, NY, USA (JIM)Icahn School of Medicine at Mount Sinai
700    1_
$a Garcia, Gabriela $u , Memphis, TN, USA (RN-M, CN, AN, PV-R, GG, PV-M); Departments of Global Health and Population and Epidemiology, Harvard TH Chan School of Public Health, LifeDoc Health, Boston, MA, USA (RN-M, JPG-R); Harvard University, Caracas, Venezuela (RN-M, DdO, JPG-R); Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Memphis, TN, USA (CN, AV-R, PV-M); International Clinical Research Centre (ICRC), LifeDoc Research, Czech Republic (JPG-R); and The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, and Division of Endocrinology, Diabetes and Bone Disease, St Anne's University Hospital Brno (FNUSA), New York, NY, USA (JIM)Icahn School of Medicine at Mount Sinai
700    1_
$a González-Rivas, Juan P $u , Memphis, TN, USA (RN-M, CN, AN, PV-R, GG, PV-M); Departments of Global Health and Population and Epidemiology, Harvard TH Chan School of Public Health, LifeDoc Health, Boston, MA, USA (RN-M, JPG-R); Harvard University, Caracas, Venezuela (RN-M, DdO, JPG-R); Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Memphis, TN, USA (CN, AV-R, PV-M); International Clinical Research Centre (ICRC), LifeDoc Research, Czech Republic (JPG-R); and The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, and Division of Endocrinology, Diabetes and Bone Disease, St Anne's University Hospital Brno (FNUSA), New York, NY, USA (JIM)Icahn School of Medicine at Mount Sinai $1 https://orcid.org/0000000176767900
700    1_
$a Mechanick, Jeffrey I $u , Memphis, TN, USA (RN-M, CN, AN, PV-R, GG, PV-M); Departments of Global Health and Population and Epidemiology, Harvard TH Chan School of Public Health, LifeDoc Health, Boston, MA, USA (RN-M, JPG-R); Harvard University, Caracas, Venezuela (RN-M, DdO, JPG-R); Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Memphis, TN, USA (CN, AV-R, PV-M); International Clinical Research Centre (ICRC), LifeDoc Research, Czech Republic (JPG-R); and The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, and Division of Endocrinology, Diabetes and Bone Disease, St Anne's University Hospital Brno (FNUSA), New York, NY, USA (JIM)Icahn School of Medicine at Mount Sinai
700    1_
$a Velasquez-Mieyer, Pedro $u , Memphis, TN, USA (RN-M, CN, AN, PV-R, GG, PV-M); Departments of Global Health and Population and Epidemiology, Harvard TH Chan School of Public Health, LifeDoc Health, Boston, MA, USA (RN-M, JPG-R); Harvard University, Caracas, Venezuela (RN-M, DdO, JPG-R); Foundation for Clinic, Public Health, and Epidemiology Research of Venezuela (FISPEVEN INC), Memphis, TN, USA (CN, AV-R, PV-M); International Clinical Research Centre (ICRC), LifeDoc Research, Czech Republic (JPG-R); and The Marie-Josée and Henry R. Kravis Center for Cardiovascular Health at Mount Sinai Heart, and Division of Endocrinology, Diabetes and Bone Disease, St Anne's University Hospital Brno (FNUSA), New York, NY, USA (JIM)Icahn School of Medicine at Mount Sinai
773    0_
$w MED00211262 $t American journal of lifestyle medicine $x 1559-8284 $g Roč. 17, č. 3 (2023), s. 336-354
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37304744 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230707 $b ABA008
991    __
$a 20230721095425 $b ABA008
999    __
$a ok $b bmc $g 1958532 $s 1196121
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 17 $c 3 $d 336-354 $e 20220603 $i 1559-8284 $m American journal of lifestyle medicine $n Am J Lifestyle Med $x MED00211262
LZP    __
$a Pubmed-20230707

Najít záznam

Citační ukazatele

Možnosti archivace